Chlorogen Funding Co-led by Burrill & Co. and Prolog Ventures

Burrill & Co. and Prolog Ventures have co-led an early-stage funding for Chlorogen, a plant-made pharmaceutical producer. The firm, which has fields in South Carolina, is involved in determining how to trigger the production of new proteins in plant chloroplasts and the extraction and refining of these proteins for use against various diseases.

The funding round totals $5 million in three tranches.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.